🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

To any adult in Northern Ireland who has not yet received the #COVID19 vaccine... for the sake of your families, for the sake of the #NHS, for your own sake... PLEASE, PLEASE PLEASE get vaccinated ASAP. bbc.co.uk/news/uk-northe…

Tips for coping with cancer - day 9 - DON'T GET HUNG UP ON SURVIVAL RATES! These tips are my personal advice based on what I've seen during 8 years with stage 4 bowel cancer as a patient and volunteer. I hope they're helpful, if so please share. Big hugs Steve #stage4tips

How is the #healthecon literature incorporating #admindata into research on #bowelcancer? Find out in our recent paper published in the European Journal of Cancer Care 👇 ➡️edin.ac/3yb3tjz⬅️ #peoplemakedata #datachangeslives Elizabeth Lemmon Catherine Hanna Peter Hall

Join the EHE Team! Edinburgh Clinical Trials Unit are looking for a Grade 7 Health Economist for 1 year at first instance. Details in link. elxw.fa.em3.oraclecloud.com/hcmUI/Candidat…

How can researchers help improve the care of patients diagnosed with oesophageal (gullet) and gastric (stomach) cancers? Our survey is now open and we want to hear from patients, their carers and family members, as well as the healthcare professionals who look after them.

Check this out Carruthers Radiation Lab Campbell Roxburgh Catherine Hanna OCathail.SM RadNetCRUKGlasgow

At last count, well under 10% of UK academic oncology spend went on radiation research. Imagine what we could do with 20%! #voteradiotherapy #radonc Follow us on Bluesky @ICR-CTSU @RM_Radiotherapy

If you’re at NCRI Partnership Festival this week then check out our e-Poster on #colorectalcancer treatment and outcomes in Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Catherine Hanna Peter Hall Katharina Diernberger Eva Morris Bowel Cancer Intelligence UK

I'm so happy to be able to share this work and its open access thanks to UofG! Big thanks also to my co-authors Katie Robb Catherine Hanna Ever wondered how to categorise pictures used in cancer screening info.. well.. have I got treat for you tandfonline.com/doi/full/10.10…

Delighted to share this really interesting work by Lauren Gatting on how pictures are use in #cancer #screening. Thought provoking on how pictures are currently used in patient info leaflets and how this can be improved. Katie Robb

Seminars in Radiation Oncology is pleased to share from January’s issue “Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date” by Dr. Sarah Derby, Dr. Chalmers @ProfAJChalmers, and Dr. Ross Carruthers UofG Cancer Sciences, nam02.safelinks.protection.outlook.com/?url=https%3A%…

What's the opposite of a #manel y'all? 💪💪💪 #womanel in action at the General Session at GI ASCO #GI2022. Key Considerations in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. Nancy You Andrea Cercek @HannaSanoff & Caron Jia

Let’s go!!!!! Next phase of foxtrot-study officially started ✅ Congratulations to CHFT Research Sam & thanks to our other sites working hard to open in such challenging times. Incredible NHS partners delivering 🇬🇧 research #crcsm Leeds CTRU

#PRIMERT rectal trial safety run-in complete without concern 👏 Looking forward to main trial to assess roll of IO & CRT or SCRT in shaping immune response of #TME in cCR Campbell Roxburgh Catherine Hanna @CRUK_GlasgowCTU

Calling all trainees! we have 3 LAS Oncology posts open to application 👇 ➡️LAS post in Med Onc: jobs.hscni.net/Job/19110/7182… ➡️LAS posts in Clin Onc: jobs.hscni.net/Job/19111/7182… If you are interested, please DM or speak to any of the team and please consider applying

Very proud to share the screen with Pete Wheatstone & Stuart Griffiths @kennycairns to discuss the foxtrot-study next steps & its relevance to patients 😀

Great to see main PRIME-RT trial now open across multiple U.K. sites after a successful safety lead in! We are combining Durvalumab with extended neoadjuvant strategies with aim of ⬆️ organ preservation in #rectalcancer. Organ preservation is important! For personal view see👇

Fantastic to see so many UK trials presented in the late breaking session #ESTRO2022 #NCRI_CTRad

How to make clinical trials succeed? Absolute masterclass in clinical trial delivery by David Palma, MD, PhD at #ESTRO2022. Most of these have been hard won lessons for me; others are ‘poorly kept secrets’ amongst clinical trialists (e.g. the misestimates of recruitment rates!) #radonc

Early results from the CAO/ARO/AIO-16 phase II trial of TNT for organ preservation in (locally) advanced rectal cancer LCRT + consolidation chemo for ‘RAPIDO’-like tumours ➡️ 40% complete response! Congratulations to Cihan Gani and colleagues #ESTRO202